| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| 2021 | 2018 | LINEAGE CELL THERAPEUTICS, INC. | 2173 SALK AVE STE 200 | CARLSBAD | CA | 92008-7354 | SAN DIEGO | USA | R44EY027654 | Retinal tissue derived from human pluripotent stem cells for vision restoration | 000 | 2 | NIH | 12/2/2020 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = -$385,923 ) |
| 2020 | 2018 | LINEAGE CELL THERAPEUTICS, INC. | 2173 SALK AVE STE 200 | CARLSBAD | CA | 92008-7354 | SAN DIEGO | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 000 | 1 | NIH | 4/3/2020 | -$385,923 |
|
 | Issue Date FY: 2019 ( Subtotal = $670,621 ) |
| 2019 | 2019 | BIOTIME, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R44EY027654 | Retinal tissue derived from human pluripotent stem cells for vision restoration | 000 | 2 | NIH | 7/26/2019 | $670,621 |
| 2019 | 2018 | BIOTIME, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 000 | 1 | NIH | 6/4/2019 | $0 |
|
 | Issue Date FY: 2018 ( Subtotal = $1,129,268 ) |
| 2018 | 2018 | BIOTIME, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 000 | 1 | NIH | 4/5/2018 | $385,923 |
| 2018 | 2018 | BIOTIME, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R41NS105263 | Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Stroke | 001 | 1 | NIH | 8/14/2018 | $0 |
| 2018 | 2018 | BIOTIME, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R44EY027654 | Retinal tissue derived from human pluripotent stem cells for vision restoration | 000 | 2 | NIH | 6/26/2018 | $743,345 |
|
 | Issue Date FY: 2017 ( Subtotal = $816,848 ) |
| 2017 | 2017 | BIOTIME, INC. | 1010 ATLANTIC AVE STE 102 | ALAMEDA | CA | 94501-1147 | ALAMEDA | USA | R44EY027654 | Retinal tissue derived from human pluripotent stem cells for vision restoration | 000 | 1 | NIH | 9/12/2017 | $816,848 |
|
 | Issue Date FY: 2014 ( Subtotal = $787,434 ) |
| 2014 | 2014 | BIOTIME INC | 1301 HARBOR BAY PARKWAY | ALAMEDA | CA | 94502 | ALAMEDA | USA | R43GM108198 | Cell Targeting Peptides for Isolating Patient Specific Stem Cells | 000 | 1 | NIH | 5/5/2014 | $224,911 |
| 2014 | 2013 | BIOTIME INC | 1301 HARBOR BAY PARKWAY | ALAMEDA | CA | 94502 | ALAMEDA | USA | R43GM105155 | Reagents for Targeted Ablation of Residual Contaminating Pluripotent Stem Cells | 001 | 2 | NIH | 2/24/2014 | $270,262 |
| 2014 | 2013 | BIOTIME INC | 1301 HARBOR BAY PARKWAY | ALAMEDA | CA | 94502 | ALAMEDA | USA | R43GM106638 | Rapid Multiplexed Nanoprobe Assays for Pluripotent Stem Cell Differentiation | 001 | 2 | NIH | 3/19/2014 | $292,261 |
|
 | Issue Date FY: 2013 ( Subtotal = $562,523 ) |
| 2013 | 2013 | BIOTIME INC | 935 PARDEE STREET | BERKELEY | CA | 94710 | ALAMEDA | USA | R43GM105155 | Reagents for Targeted Ablation of Residual Contaminating Pluripotent Stem Cells | 002 | 2 | NIH | 2/24/2014 | $270,262 |
| 2013 | 2013 | BIOTIME INC | 935 PARDEE STREET | BERKELEY | CA | 94710 | ALAMEDA | USA | R43GM106638 | Rapid Multiplexed Nanoprobe Assays for Pluripotent Stem Cell Differentiation | 002 | 2 | NIH | 3/19/2014 | $292,261 |
| 2013 | 2011 | BIOTIME INC | 1301 HARBOR BAY PARKWAY | ALAMEDA | CA | 94502 | ALAMEDA | USA | R43GM096795 | BIODEGRADABLE, HYALURONIC ACID-BASED MICROCARRIERS FOR MESENCHYMAL STEM CELL PROP | 000 | 1 | NIH | 8/26/2013 | $0 |
|
 | Issue Date FY: 2011 ( Subtotal = $335,900 ) |
| 2011 | 2011 | BIOTIME INC | 935 PARDEE STREET | BERKELEY | CA | 94710 | ALAMEDA | USA | R43GM096795 | BIODEGRADABLE, HYALURONIC ACID-BASED MICROCARRIERS FOR MESENCHYMAL STEM CELL PROP | 000 | 1 | NIH | 9/26/2011 | $335,900 |
|
 | Issue Date FY: 2005 ( Subtotal = $149,996 ) |
| 2005 | 2005 | BIOTIME INC | 935 PARDEE STREET | BERKELEY | CA | 94710 | ALAMEDA | USA | R41HL074648 | RESUSCITATING BLOOD-SUBSTITUTED HYPOTHERMIC DOGS | 000 | 2 | NIH | 4/6/2005 | $149,996 |
|
 | Issue Date FY: 2004 ( Subtotal = $149,994 ) |
| 2004 | 2004 | BIOTIME INC | 935 PARDEE STREET | BERKELEY | CA | 94710 | ALAMEDA | USA | R41HL074648 | RESUSCITATING BLOOD-SUBSTITUTED HYPOTHERMIC DOGS | 000 | 1 | NIH | 3/25/2004 | $149,994 |
|
|